A federal judge appeared skeptical Friday of the US government’s planned implementation of a drug rebate pilot, weighing whether the program should be temporarily halted before it goes into effect in January.
“How can you claim to consider administrative costs if you don’t know the costs” of implementing the 340B Rebate Model Pilot Program, Chief Judge
“What I am gathering” is that the agency is still processing information about the costs and impact ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.